Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Auddia Inc. stock logo
AUUD
Auddia
$1.00
$1.14
$0.82
$19.64
$5.80M0.53.06 million shs112,683 shs
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
$2.97
-14.2%
$3.69
$0.32
$5.84
$4.72M1.192.80 million shs213,407 shs
OMNIQ Corp. stock logo
OMQS
OMNIQ
$0.09
-7.9%
$0.12
$0.08
$0.27
$1.40M1.4310,714 shs140 shs
YDKG
Yueda Digital
$0.91
+0.0%
$0.98
$0.73
$600.00
$5.01M1.2996,446 shs16,644 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Auddia Inc. stock logo
AUUD
Auddia
-2.91%0.00%-4.76%-23.66%-94.04%
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
-3.35%-14.36%+18.90%-42.90%+24.91%
OMNIQ Corp. stock logo
OMQS
OMNIQ
-15.97%-8.34%-12.74%-10.71%+4.93%
YDKG
Yueda Digital
-2.72%-12.15%-15.43%-4.75%+90,489,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Auddia Inc. stock logo
AUUD
Auddia
$1.00
$1.14
$0.82
$19.64
$5.80M0.53.06 million shs112,683 shs
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
$2.97
-14.2%
$3.69
$0.32
$5.84
$4.72M1.192.80 million shs213,407 shs
OMNIQ Corp. stock logo
OMQS
OMNIQ
$0.09
-7.9%
$0.12
$0.08
$0.27
$1.40M1.4310,714 shs140 shs
YDKG
Yueda Digital
$0.91
+0.0%
$0.98
$0.73
$600.00
$5.01M1.2996,446 shs16,644 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Auddia Inc. stock logo
AUUD
Auddia
-2.91%0.00%-4.76%-23.66%-94.04%
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
-3.35%-14.36%+18.90%-42.90%+24.91%
OMNIQ Corp. stock logo
OMQS
OMNIQ
-15.97%-8.34%-12.74%-10.71%+4.93%
YDKG
Yueda Digital
-2.72%-12.15%-15.43%-4.75%+90,489,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Auddia Inc. stock logo
AUUD
Auddia
1.00
SellN/AN/A
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
1.00
SellN/AN/A
OMNIQ Corp. stock logo
OMQS
OMNIQ
0.00
N/AN/AN/A
YDKG
Yueda Digital
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest OMQS, ENTO, AUUD, and YDKG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
YDKG
Yueda Digital
DowngradeSell (D)Sell (D-)
8/24/2026
Auddia Inc. stock logo
AUUD
Auddia
UpgradeSell (E)Sell (E+)
8/5/2026
Auddia Inc. stock logo
AUUD
Auddia
DowngradeSell (E+)Sell (E)
7/20/2026
Auddia Inc. stock logo
AUUD
Auddia
UpgradeSell (E)Sell (E+)
7/2/2026
Auddia Inc. stock logo
AUUD
Auddia
DowngradeSell (E+)Sell (E)
6/18/2026
Auddia Inc. stock logo
AUUD
Auddia
UpgradeSell (E)Sell (E+)
6/17/2026
YDKG
Yueda Digital
UpgradeSell (D-)Sell (D)
6/4/2026
Auddia Inc. stock logo
AUUD
Auddia
DowngradeSell (E+)Sell (E)
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Auddia Inc. stock logo
AUUD
Auddia
N/AN/AN/AN/A$1.84 per shareN/A
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
N/AN/AN/AN/A($2.45) per shareN/A
OMNIQ Corp. stock logo
OMQS
OMNIQ
$81.19M0.02N/AN/A($3.28) per share-0.03
YDKG
Yueda Digital
$28.15M0.18N/AN/A$56.35 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Auddia Inc. stock logo
AUUD
Auddia
-$7.69M-$18.04N/AN/AN/AN/A-175.41%-153.38%N/A
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
-$18.06M-$1.69N/AN/AN/AN/A-461.02%-14.72%N/A
OMNIQ Corp. stock logo
OMQS
OMNIQ
-$29.43M-$0.20N/AN/AN/A-34.33%N/A-61.97%N/A
YDKG
Yueda Digital
-$28.06MN/AN/AN/AN/AN/AN/AN/AN/A

Latest OMQS, ENTO, AUUD, and YDKG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Auddia Inc. stock logo
AUUD
Auddia
-$3.85-$0.71+$3.14-$0.71$0.01 million$0.01 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Auddia Inc. stock logo
AUUD
Auddia
N/AN/AN/AN/AN/A
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
N/AN/AN/AN/AN/A
OMNIQ Corp. stock logo
OMQS
OMNIQ
N/AN/AN/AN/AN/A
YDKG
Yueda Digital
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Auddia Inc. stock logo
AUUD
Auddia
N/A
11.34
11.34
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
N/A
2.62
2.62
OMNIQ Corp. stock logo
OMQS
OMNIQ
N/A
0.34
0.26
YDKG
Yueda Digital
N/A
203.48
638.68

Institutional Ownership

CompanyInstitutional Ownership
Auddia Inc. stock logo
AUUD
Auddia
N/A
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
12.30%
OMNIQ Corp. stock logo
OMQS
OMNIQ
5.65%
YDKG
Yueda Digital
1.02%

Insider Ownership

CompanyInsider Ownership
Auddia Inc. stock logo
AUUD
Auddia
1.60%
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
0.75%
OMNIQ Corp. stock logo
OMQS
OMNIQ
11.60%
YDKG
Yueda Digital
7.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Auddia Inc. stock logo
AUUD
Auddia
205.80 million5.71 millionNot Optionable
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
91.59 million3.34 millionN/A
OMNIQ Corp. stock logo
OMQS
OMNIQ
19015.15 million9.47 millionNot Optionable
YDKG
Yueda Digital
705.54 million5.13 millionN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Auddia stock logo

Auddia NASDAQ:AUUD

$1.00 0.00 (0.00%)
As of 04:00 PM Eastern

Auddia Inc., a technology company, develops AI Platform for the audio and podcast markets. The company's flagship product is faidr, which enables consumers to listen to various AM/FM radio station with commercial breaks replaced with personalized audio content, including popular and new music, news, and weather. It also provides Vodacast mobile app, an interactive differentiated podcasting that allows podcasters to give their audiences an interactive audio experience; and Podcast Hub, a content management system. The company was formerly known as Clip Interactive, LLC and changed its name to Auddia Inc. in November 2019. Auddia Inc. was founded in 2012 and is headquartered in Boulder, Colorado.

Entero Therapeutics stock logo

Entero Therapeutics NASDAQ:ENTO

$2.97 -0.49 (-14.16%)
As of 09/3/2026

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company's pipeline candidates include latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides, currently under Phase 2 studies; and capeserod, a selective 5-HT4 receptor partial agonist under Phase 1 studies for the treatment of gastroparesis. It is also involved in the development of adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, currently under Phase 2 studies for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis; and niclosamide, an oral small molecule with anti-inflammatory inhibitor therapy, currently under Phase 2 studies for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, as well as immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is based in Boca Raton, Florida.

OMNIQ stock logo

OMNIQ NASDAQ:OMQS

$0.09 -0.01 (-7.90%)
As of 10:40 AM Eastern

OMNIQ Corp. provides artificial intelligence-based solutions in the United States. The company provides artificial intelligence technology to deliver data collection, real-time surveillance, and monitoring for supply chain management, homeland security, public safety, traffic and parking management, and access control applications. It offers solutions which includes hardware, software, communications, and automated management services; technical service and support; distributes barcode labels, tags, and ribbons, as well as RFID labels and tags; and provides printing solutions, credit card terminals, automatic kiosks, and point-of-care units, as well as packaged and configurable software, and mobile and wireless equipment. In addition, the company offers suite of configurable packaged software solutions comprises order entry, an access to real-time information and up-to-date data to facilitates and streamline job function; intelligent order entry, a link in getting remote orders from the field to corporate; warehouse, a collection of applications for portable devices that extend the existing system out to the warehouse floor and dock doors; proof of delivery which offers proof-of-delivery capabilities; Quest Total solutions as a service, mobile-services offering that includes hardware, software, and wireless data in a bundled subscription; and media and label business that provides data collection from ongoing and repeatable purchasing business. It sells its products to government agencies and Fortune 500 companies in various sectors, including healthcare, food and beverage, manufacturing, retail, distribution, and transportation and logistics sectors. The company was formerly known as Quest Solution, Inc. OMNIQ Corp. was incorporated in 1973 and is based in Salt Lake City, Utah.

Yueda Digital NASDAQ:YDKG

$0.90 +0.00 (+0.01%)
As of 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AirMedia Group Inc. operates out-of-home advertising platforms primarily in the People's Republic of China. The company operates a network of digital TV screens on planes operated by five airlines; and gas station media network, as well as other outdoor media advertising platforms in gas stations. It also displays non-advertising content, such as weather, sports, and comedy clips; and television programs, including documentaries and hidden camera type reality shows from other third-party content providers. In addition, the company holds concession rights to operate various traditional advertising media comprising light boxes, billboards, and display advertising; and install and operate Wi-Fi systems on trains administered by eight regional railway bureaus, as well as on long-haul buses. As of March 31, 2016, its programs were placed on digital TV screens on planes operated by 5 airlines; and it operated 71,904 digital TV screens on airplanes. AirMedia Group Inc. was founded in 2005 and is headquartered in Beijing, the People's Republic of China.